Synthesis and Evaluation of Aminothiazole-Paeonol Derivatives as Potential Anticancer Agents. 2016

Chia-Ying Tsai, and Mohit Kapoor, and Ying-Pei Huang, and Hui-Hsien Lin, and Yu-Chuan Liang, and Yu-Ling Lin, and Su-Chin Huang, and Wei-Neng Liao, and Jen-Kun Chen, and Jer-Shing Huang, and Ming-Hua Hsu
Nuclear Science & Technology Development Center, National Tsing Hua University, Hsinchu 30013, Taiwan. s101000017@m101.nthu.edu.tw.

In this study, novel aminothiazole-paeonol derivatives were synthesized and characterized using ¹H-NMR, (13)C-NMR, IR, mass spectroscopy, and high performance liquid chromatography. All the new synthesized compounds were evaluated according to their anticancer effect on seven cancer cell lines. The experimental results indicated that these compounds possess high anticancer potential regarding human gastric adenocarcinoma (AGS cells) and human colorectal adenocarcinoma (HT-29 cells). Among these compounds, N-[4-(2-hydroxy-4-methoxyphenyl)thiazol-2-yl]-4-methoxybenzenesulfonamide (13c) had the most potent inhibitory activity, with IC50 values of 4.0 µM to AGS, 4.4 µM to HT-29 cells and 5.8 µM to HeLa cells. The 4-fluoro-N-[4-(2-hydroxy-4-methoxyphenyl)thiazol-2-yl]benzenesulfonamide (13d) was the second potent compound, showing IC50 values of 7.2, 11.2 and 13.8 µM to AGS , HT-29 and HeLa cells, respectively. These compounds are superior to 5-fluorouracil (5-FU) for relatively higher potency against AGS and HT-29 human cancer cell lines along with lower cytotoxicity to fibroblasts. Novel aminothiazole-paeonol derivatives in this work might be a series of promising lead compounds to develop anticancer agents for treating gastrointestinal adenocarcinoma.

UI MeSH Term Description Entries
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000098 Acetophenones Derivatives of the simplest aromatic ketone acetophenone (of general formula C6H5C(O)CH3).
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013830 Thiadiazoles Heterocyclic compounds composed of a five-membered heterocyclic ring which contains one sulfur and two nitrogen atoms. Thiadiazole
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D019073 HT29 Cells Human colonic ADENOCARCINOMA cells that are able to express differentiation features characteristic of mature intestinal cells such as the GOBLET CELLS. HT-29 Cells,Cell, HT-29,Cell, HT29,Cells, HT-29,Cells, HT29,HT 29 Cells,HT-29 Cell,HT29 Cell

Related Publications

Chia-Ying Tsai, and Mohit Kapoor, and Ying-Pei Huang, and Hui-Hsien Lin, and Yu-Chuan Liang, and Yu-Ling Lin, and Su-Chin Huang, and Wei-Neng Liao, and Jen-Kun Chen, and Jer-Shing Huang, and Ming-Hua Hsu
February 2018, Molecules (Basel, Switzerland),
Chia-Ying Tsai, and Mohit Kapoor, and Ying-Pei Huang, and Hui-Hsien Lin, and Yu-Chuan Liang, and Yu-Ling Lin, and Su-Chin Huang, and Wei-Neng Liao, and Jen-Kun Chen, and Jer-Shing Huang, and Ming-Hua Hsu
August 2023, Archiv der Pharmazie,
Chia-Ying Tsai, and Mohit Kapoor, and Ying-Pei Huang, and Hui-Hsien Lin, and Yu-Chuan Liang, and Yu-Ling Lin, and Su-Chin Huang, and Wei-Neng Liao, and Jen-Kun Chen, and Jer-Shing Huang, and Ming-Hua Hsu
October 2015, Molecules (Basel, Switzerland),
Chia-Ying Tsai, and Mohit Kapoor, and Ying-Pei Huang, and Hui-Hsien Lin, and Yu-Chuan Liang, and Yu-Ling Lin, and Su-Chin Huang, and Wei-Neng Liao, and Jen-Kun Chen, and Jer-Shing Huang, and Ming-Hua Hsu
August 2019, Journal of natural products,
Chia-Ying Tsai, and Mohit Kapoor, and Ying-Pei Huang, and Hui-Hsien Lin, and Yu-Chuan Liang, and Yu-Ling Lin, and Su-Chin Huang, and Wei-Neng Liao, and Jen-Kun Chen, and Jer-Shing Huang, and Ming-Hua Hsu
January 2015, European journal of medicinal chemistry,
Chia-Ying Tsai, and Mohit Kapoor, and Ying-Pei Huang, and Hui-Hsien Lin, and Yu-Chuan Liang, and Yu-Ling Lin, and Su-Chin Huang, and Wei-Neng Liao, and Jen-Kun Chen, and Jer-Shing Huang, and Ming-Hua Hsu
October 2018, Research in pharmaceutical sciences,
Chia-Ying Tsai, and Mohit Kapoor, and Ying-Pei Huang, and Hui-Hsien Lin, and Yu-Chuan Liang, and Yu-Ling Lin, and Su-Chin Huang, and Wei-Neng Liao, and Jen-Kun Chen, and Jer-Shing Huang, and Ming-Hua Hsu
October 2014, European journal of medicinal chemistry,
Chia-Ying Tsai, and Mohit Kapoor, and Ying-Pei Huang, and Hui-Hsien Lin, and Yu-Chuan Liang, and Yu-Ling Lin, and Su-Chin Huang, and Wei-Neng Liao, and Jen-Kun Chen, and Jer-Shing Huang, and Ming-Hua Hsu
March 2013, Bioorganic & medicinal chemistry,
Chia-Ying Tsai, and Mohit Kapoor, and Ying-Pei Huang, and Hui-Hsien Lin, and Yu-Chuan Liang, and Yu-Ling Lin, and Su-Chin Huang, and Wei-Neng Liao, and Jen-Kun Chen, and Jer-Shing Huang, and Ming-Hua Hsu
January 2022, Bioorganic & medicinal chemistry letters,
Chia-Ying Tsai, and Mohit Kapoor, and Ying-Pei Huang, and Hui-Hsien Lin, and Yu-Chuan Liang, and Yu-Ling Lin, and Su-Chin Huang, and Wei-Neng Liao, and Jen-Kun Chen, and Jer-Shing Huang, and Ming-Hua Hsu
February 2018, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!